Targeted inhibition of NLRP12 inflammasome may further help to appreciate the impact of inflammation on the biology of prostate tumors, and providing new directions investigating the role of inflammasomes in prostate cancer. This evidence concerns the gene NLRP12 and prostate carcinoma.